ATE174920T1 - Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen - Google Patents

Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE174920T1
ATE174920T1 AT94400627T AT94400627T ATE174920T1 AT E174920 T1 ATE174920 T1 AT E174920T1 AT 94400627 T AT94400627 T AT 94400627T AT 94400627 T AT94400627 T AT 94400627T AT E174920 T1 ATE174920 T1 AT E174920T1
Authority
AT
Austria
Prior art keywords
pyridothiadiazines
production
pharmaceutical compositions
compositions containing
medicaments
Prior art date
Application number
AT94400627T
Other languages
English (en)
Inventor
Bernard Pirotte
Tullio Pascal De
Bernard Masereel
Jacques Delarge
Jean Lepagnol
Pierre Renard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE174920T1 publication Critical patent/ATE174920T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT94400627T 1993-03-26 1994-03-24 Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen ATE174920T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9303458A FR2703051B1 (fr) 1993-03-26 1993-03-26 Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ATE174920T1 true ATE174920T1 (de) 1999-01-15

Family

ID=9445338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94400627T ATE174920T1 (de) 1993-03-26 1994-03-24 Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen

Country Status (13)

Country Link
US (1) US5459138A (de)
EP (1) EP0618209B1 (de)
JP (1) JP2513989B2 (de)
AT (1) ATE174920T1 (de)
AU (1) AU673893B2 (de)
CA (1) CA2119853C (de)
DE (1) DE69415373T2 (de)
DK (1) DK0618209T3 (de)
ES (1) ES2128519T3 (de)
FR (1) FR2703051B1 (de)
GR (1) GR3029406T3 (de)
NZ (1) NZ260186A (de)
ZA (1) ZA942131B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
KR100444697B1 (ko) * 1995-11-15 2005-01-13 야마노우치세이야쿠 가부시키가이샤 피리도티아진유도체및이를포함하는약제학적조성물
EP0876379A1 (de) * 1996-01-17 1998-11-11 Novo Nordisk A/S Kondensierte 1,2,4-thiadiazin- und 1,4-thiazinderivate, deren herstellung und verwendung
BR9707004A (pt) * 1996-01-17 1999-07-20 Novo Nordisk As Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento
US6225310B1 (en) 1996-01-17 2001-05-01 Novo Nordisk A/S Fused 1,2,4-thiadiazine derivatives, their preparation and use
CA2250856A1 (en) * 1996-04-19 1997-10-30 The Regents Of The University Of California Treatment of mood/affective disorders by glutamatergic upmodulators
DE122009000052I2 (de) * 1996-09-24 2009-12-31 Dow Agrosciences Llc N-((1,2,4)triazoloazinyl)benzolsulfonamid- und pyridinsulfonamidverbindungen und deren verwendung als herbizide
US6329368B1 (en) * 1997-05-09 2001-12-11 The Regents Of The University Of California Endocrine modulation with positive modulators of AMPA type glutamate receptors
JP2001510195A (ja) * 1997-07-16 2001-07-31 ノボ ノルディスク アクティーゼルスカブ 縮合化１，２，４−チアジアジン誘導体、その調製及び使用
WO1999032495A1 (en) * 1997-12-19 1999-07-01 Novo Nordisk A/S Pyrido 1,2,4-thiadiazine derivatives, their preparation and use
DE19824232A1 (de) * 1998-05-29 1999-12-02 Bayer Ag Pyridodithiazindioxide
DE19918021C1 (de) 1999-04-21 2000-06-29 Ruetgers Organics Gmbh Verfahren zur Herstellung von chlorierten Pyridinsulfonsäurechloriden
EP1194430A1 (de) * 1999-06-30 2002-04-10 Novo Nordisk A/S Verfahren
NZ521852A (en) 2000-03-20 2004-10-29 Teva Pharma Novel processes for preparing torsemide intermediate
AU2001265841A1 (en) * 2000-06-26 2002-01-08 Novo-Nordisk A/S Use of potassium channel openers for the treatment of insulitis
CA2446161A1 (en) * 2001-05-04 2002-11-14 Emanuele Sher Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes
US7902203B2 (en) 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
US7378414B2 (en) 2003-08-25 2008-05-27 Abbott Laboratories Anti-infective agents
US7492956B2 (en) * 2004-08-18 2009-02-17 Cisco Technology, Inc. Video coding using multi-dimensional amplitude coding and 2-D non-zero/zero cluster position coding
DE602005020462D1 (de) 2004-08-25 2010-05-20 Essentialis Inc Pharmazeutische formulierungen von kalium-atp-kanalöffnern und deren verwendungen
WO2006093801A1 (en) * 2005-02-25 2006-09-08 Abbott Laboratories Thiadiazine derivatives useful as anti-infective agents
EP1777219A1 (de) * 2005-10-20 2007-04-25 Faust Pharmaceuticals 1,2-Substituierte-Naphthalen-Derivate mit antiglutamatergen Eigenschaften und deren Verwendungen
US7799777B2 (en) * 2006-01-05 2010-09-21 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
CN100393726C (zh) * 2006-04-20 2008-06-11 山东大学 2,4-二取代杂环并[4,5-e][1,2,4]噻二嗪衍生物制备方法
CN110054647B (zh) * 2019-05-23 2021-06-15 上海勋和医药科技有限公司 托拉塞米磷酸酯类前药、其制备方法及组合物
BR112022007208A2 (pt) * 2019-10-30 2022-07-26 Janssen Sciences Ireland Unlimited Co Síntese de 3-nitro-n-(2,2,2-trifluoroetil)-4-piridinamina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157647A (en) * 1960-10-31 1964-11-17 Olin Mathieson Process for producing nu-alkyl and nu-aralkyl thiadiazine compounds
US3288678A (en) * 1963-09-12 1966-11-29 Ciba Geigy Corp Diuretic compositions
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
JPS5854158B2 (ja) * 1975-10-02 1983-12-02 ヒサミツセイヤク カブシキガイシヤ シンキナピリドチアジアジンユウドウタイノセイゾウホウ

Also Published As

Publication number Publication date
GR3029406T3 (en) 1999-05-28
FR2703051A1 (fr) 1994-09-30
JP2513989B2 (ja) 1996-07-10
FR2703051B1 (fr) 1995-04-28
ZA942131B (en) 1995-04-05
AU5904894A (en) 1994-09-29
NZ260186A (en) 1995-07-26
EP0618209B1 (de) 1998-12-23
CA2119853A1 (fr) 1994-09-27
DE69415373D1 (de) 1999-02-04
CA2119853C (fr) 2002-09-10
DE69415373T2 (de) 1999-08-26
US5459138A (en) 1995-10-17
AU673893B2 (en) 1996-11-28
JPH072872A (ja) 1995-01-06
ES2128519T3 (es) 1999-05-16
EP0618209A1 (de) 1994-10-05
DK0618209T3 (da) 1999-08-23

Similar Documents

Publication Publication Date Title
ATE174920T1 (de) Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE128458T1 (de) Naphtylalkylamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE122035T1 (de) Naphthylethylharnstoff und naphthylethylthioharnstoff verbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ATE124047T1 (de) Oxazolopyridinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
ATE145904T1 (de) Isochinolin-5-yl-sulfonsäureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
ATE156829T1 (de) Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
AU656466B2 (en) New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
ATE152707T1 (de) Neue naphthalin-amide und sulfonamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE160338T1 (de) Alpha aminosäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE118212T1 (de) 1-(alkoxybenzyl)piperazineamide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE214051T1 (de) Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
ATE170520T1 (de) Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE123776T1 (de) Aminoalkylchromone, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
FI903701A0 (fi) Reninhaemmande amino-oligohydroxiderivat.
ATE140216T1 (de) (cyclohexyl)alkenderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE152710T1 (de) (thia)cycloalkyl(b)indole, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen
ATE153995T1 (de) Cyclizierte analoge der fettsäurenmetaboliten, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification